The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Employment - Bexion
Leadership - Bexion
Stock and Other Ownership Interests - Bexion
Consulting or Advisory Role - Bexion
Research Funding - Bexion
A phase 1 study to evaluate the safety and tolerability of BXQ-350, a novel sphingolipid metabolism modulator, in pediatric diffuse intrinsic pontine glioma and diffuse midline glioma.
 
Tariq Arshad
Employment - Bexion
Leadership - Bexion
Stock and Other Ownership Interests - Bexion
Research Funding - Bexion
 
Michael Gazda
No Relationships to Disclose
 
Jim Beach
Employment - Bexion
Leadership - Bexion
Stock and Other Ownership Interests - Bexion
Consulting or Advisory Role - Bexion
Research Funding - Bexion
 
Kathleen Dorris
No Relationships to Disclose
 
Margot Lazow
Research Funding - Novartis (Inst)
 
Trent Hummel
No Relationships to Disclose
 
Richard Curry
Employment - CTI
 
Adam Creighbaum
Employment - Bexion
Stock and Other Ownership Interests - Bexion
Research Funding - Bexion